Does Rallies show 13F holders for CBUS?

Yes. Rallies tracks hedge fund and 13F ownership data for CBUS, including fund names, share counts, latest tracked quarter, and position changes when available.

Is CBUS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CBUS. It does not provide personalized investment advice.

CBUS (Cibus, Inc. Class A Common Stock) Stock Analysis - Hedge Fund Holdings

Cibus, Inc. Class A Common Stock (CBUS) is a publicly traded Healthcare sector company. As of May 21, 2026, CBUS trades at $1.42 with a market cap of $97.70M and a P/E ratio of -0.13. CBUS moved +8.46% today. Year to date, CBUS is -29.70%; over the trailing twelve months it is -49.73%. Its 52-week range spans $1.09 to $6.10. Analyst consensus is buy with an average price target of $14.67. Rallies surfaces CBUS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns CBUS stock?

Hedge funds tracked by Rallies that own CBUS include Davidson Kempner and Glenview Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Cibus, Inc. Class A Common Stock.

CBUS Key Metrics

Key financial metrics for CBUS
Metric	Value
Price	$1.42
Market Cap	$97.70M
P/E Ratio	-0.13
EPS	$-10.83
Dividend Yield	0.00%
52-Week High	$6.10
52-Week Low	$1.09
Volume	0
Avg Volume	0
Revenue (TTM)	$4.26M
Net Income	$-282.71M
Gross Margin	0.00%

Top Hedge Funds Holding CBUS

Davidson Kempner holds 1.53M shares of CBUS, changed +0.00% as of Mar 31, 2026.
Glenview Capital holds 116.47K shares of CBUS, changed +0.00% as of Mar 31, 2024.

Latest CBUS News

Cibus Raises $37M but Logs $21.2M Loss, Rice Launch Delayed to 2029 — May 15, 2026
Cibus Transfers Gene-Edited Rice Herbicide Tolerance Traits to Interoc for Testing and Production in South America — May 4, 2026
Cibus Prices 6.98 Million Share Offering at $2.15 to Raise $15M — Mar 26, 2026
Cibus Inc Cuts Expenses and Secures $200M Rice Partnerships Despite $31.9M Q4 Loss — Mar 18, 2026

Recent CBUS Insider Trades

Sauer Noel sold 4 (~$5.94) on Jun 13, 2025.
Prante Gerhard sold 1.15K (~$2.21K) on Feb 25, 2025.
Prante Gerhard sold 1.15K (~$2.38K) on Feb 24, 2025.

CBUS Analyst Consensus

3 analysts cover CBUS: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $14.67.

Common questions about CBUS

Who owns CBUS stock?: Hedge funds tracked by Rallies that own CBUS include Davidson Kempner and Glenview Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Cibus, Inc. Class A Common Stock.
Does Rallies show 13F holders for CBUS?: Yes. Rallies tracks hedge fund and 13F ownership data for CBUS, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CBUS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CBUS. It does not provide personalized investment advice.